| 34.18 Data as of Jun 06 |  +0.87 / +2.61%Today’s Change | 17.25 Today|||52-Week Range 58.91 | +27.92% Year-to-Date |
| Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Drugs Winner Jun 03 / TheStreet.com |
| Previous close | 33.31 |
| Today’s open | 33.22 |
| Day’s range | -- - -- |
| Volume | 701,490 |
| Average volume (3 months) | 1,796,641 |
| Market cap | $2.0B |
| Dividend yield | 2.93% |
| Earnings growth (last year) | +159.50% |
| Earnings growth (this year) | +20.29% |
| Earnings growth (next 5 years) | +21.00% |
| Revenue growth (last year) | +133.44% |
| P/E ratio | 10.6 |
| Price/Sales | 3.16 |
| Price/Book | 12.05 |
| Today’s change | Today’s % change | |
|---|---|---|
| OPKOPKO Health Inc | +0.38 | +6.16% |
| ARNAArena Pharmaceutical... | +0.03 | +0.35% |
| CLVSClovis Oncology Inc | +2.31 | +3.30% |
| MNKDMannkind Corp | +0.22 | +2.96% |
| Next reporting date | July 31, 2013 |
| EPS forecast (this quarter) | $0.98 |
| Annual revenue (last year) | $509.3M |
| Annual profit (last year) | $197.7M |
| Net profit margin | 38.81% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Don Matthew Bailey, MBA |
Chief Operating Officer Stephen Lahue Cartt, MBA |
Corporate headquarters Anaheim, California |
.
